StockData
Delcath Systems, Inc. logo

Delcath Systems, Inc. (DCTH) shareholders

DCTHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/30
$19.37−0.50 (-2.52%)

Close on Nov 17, 2026Market cap $672.12MP/E 1937.0Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
50.2%
17M of 35M shares
Institutional holders
120
20 new, 20 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
3 buys · 2 sales
Net sold $299.15K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Rosalind Advisors, Inc.
Joint filing with Salamon Steven A J (9.90%), Aharon Gil (9.90%)
6,692,4919.90%13D (active) amendmentOct 13, 2026
BlackRock Portfolio Management LLC2,180,4936.30%13G (passive)Sep 30, 2026
BlackRock, Inc.1,836,1215.30%13G (passive)Jun 30, 2026
Daniel Kaufman1,766,4325.08%13G (passive)Mar 18, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of DCTHValueChange% of portfolio
Rosalind Advisors, Inc.3,300,3899.51%$41.55M–15.44%
BlackRock, Inc.2,706,8027.80%$34.08M+922,3360.00%
Vanguard Capital Management LLC1,221,2473.52%$15.38M−108,0410.00%
Propel Bio Management, LLC871,4602.51%$10.97M−108,2385.74%
Geode Capital Management, LLC733,1152.11%$9.23M+41,0840.00%
State Street Corp679,2801.96%$8.55M+14,8520.00%
Algert Global LLC580,7081.67%$7.31M+434,9750.09%
Millennium Management LLC566,3711.63%$7.13M−21,6840.00%
Divisadero Street Capital Management, LP499,7961.44%$6.29M–0.14%
Morgan Stanley407,9831.18%$5.14M+22,4590.00%
ExodusPoint Capital Management, LP359,8841.04%$4.53M+323,9160.03%
Private Wealth Advisors, LLC310,8630.90%$3.91M−280,6611.00%
Simplify Asset Management Inc.264,7700.76%$3.33M+3,6440.05%
Northern Trust Corp252,1080.73%$3.17M+2450.00%
Goldman Sachs Group Inc250,3120.72%$3.15M−38,8190.00%
ADAR1 Capital Management, LLC224,3850.65%$2.83M–0.13%
Marshall Wace, Llp218,9630.63%$2.76M+27,3330.00%
Dimensional Fund Advisors LP210,2980.61%$2.65MNew0.00%
Kennedy Capital Management LLC204,1430.59%$2.57M−3,7800.05%
Vanguard Portfolio Management LLC193,4480.56%$2.44M+15,4120.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202612017M50.2%20 / 4826 / 203M2M
Q1 202612116M47.0%27 / 3736 / 234M3M
Q4 202511917M49.4%18 / 4236 / 192M3M
Q3 202512418M52.1%31 / 3936 / 244M4M
Q2 202511718M52.9%49 / 3919 / 297M4M
Q1 20259815M43.5%20 / 4126 / 125M4M
Q4 20249014M39.4%30 / 3313 / 85M1M
Q3 20246910M30.0%23 / 1714 / 52M2M
Q2 20245210M30.2%19 / 1710 / 33M2M
Q1 2024369M24.8%2 / 1312 / 83M1M
Q4 2023427M19.9%11 / 195 / 73M4M
Q3 2023387M20.4%11 / 128 / 43M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

112 funds held DCTH in Q2 2026, 62% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of DCTHValue% of fundAs of
Vanguard Total Stock Market Index Fund889,4102.56%$11.20M0.00%Jun 30, 2026
iShares Russell 2000 ETF757,1962.18%$9.53M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund314,2750.91%$3.84M0.01%Jul 31, 2026
Vanguard Extended Market Index Fund304,8090.88%$3.84M0.00%Jun 30, 2026
Simplify Propel Opportunities ETF261,1260.75%$3.29M4.26%Jun 30, 2026
iShares Russell 2000 Value ETF229,8090.66%$2.89M0.02%Jun 30, 2026
North Square Dynamic Small Cap Fund192,3630.55%$2.07M0.26%May 31, 2026
Vanguard Russell 2000 Index Fund154,9420.45%$1.67M0.01%May 31, 2026
College Retirement Equities Fund - Total Global Stock Account141,2290.41%$1.78M0.00%Jun 30, 2026
Fidelity Extended Market Index Fund140,1700.40%$1.51M0.00%May 31, 2026
Small Cap Equity Fund122,7000.35%$1.54M0.15%Jun 30, 2026
BlackRock Advantage Small Cap Core Fund100,8990.29%$1.09M0.02%May 29, 2026
iShares Micro-Cap ETF96,6980.28%$1.22M0.08%Jun 30, 2026
BlackRock Advantage Small Cap Growth Fund73,4050.21%$924.17K0.11%Jun 30, 2026
Schwab Small-Cap Index Fund70,4570.20%$860.98K0.01%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Gerard J. MichelCHIEF EXECUTIVE OFFICER, Director342,0340.99%Mar 3, 2026
Sandra PennellChief Financial Officer77,0180.22%Mar 6, 2026
David L. HoffmanGEN'L COUNSEL, CCO & SECY74,3300.21%Feb 18, 2026
Vojo VukovicCHIEF MEDICAL OFFICER168,8820.49%Feb 18, 2026
Kevin MuirGM INTERVENTIONAL ONCOLOGY18,5820.05%Feb 18, 2026
Martha S. RookCHIEF OPERATING OFFICER––Feb 18, 2026
Bridget A. MartellDirector0–Nov 13, 2026
Rosalind Advisors, Inc.Director3,389,5939.77%Oct 14, 2026
Gil AharonDirector4,483,17812.92%Oct 14, 2026
Steven A. J. SalamonDirector4,534,49313.07%Oct 14, 2026
John Richard SylvesterDirector14,9360.04%May 14, 2026
Elizabeth CzerepakDirector––May 14, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bridget A. Martell
Director
Nov 12, 2026Sale−1,930$22.26$42.96K0
Bridget A. Martell
Director
Nov 12, 2026Sale−20,570$21.66$445.55K1,930
Bridget A. Martell
Director
Nov 12, 2026Option exercise+22,500$7.85$176.63K22,500
Rosalind Advisors, Inc.
Director
Oct 13, 2026Other−27,502––3,389,593
Rosalind Advisors, Inc.
Director
Oct 13, 2026Conversion+3,627––3,417,095
Sandra Pennell
Chief Financial Officer
Mar 6, 2026Buy+5,533$9.04$50.02K77,018
Gerard J. Michel
CHIEF EXECUTIVE OFFICER, Director
Mar 2, 2026Buy+11,200$8.96$100.35K342,034
John Richard Sylvester
Director
Nov 21, 2025Buy+4,386$8.89$38.99K14,936
Gerard J. Michel
CHIEF EXECUTIVE OFFICER, Director
Nov 11, 2025Buy+11,500$8.53$98.09K330,834
Vojo Vukovic
CHIEF MEDICAL OFFICER
Jun 12, 2025Option exercise+42,000$4.78$200.76K168,882
Gil Aharon
Director
May 5, 2025Option exercise+400,000$10.00$4.00M3,413,468
Steven A. J. Salamon
Director
May 5, 2025Option exercise+400,000$10.00$4.00M3,413,468
Steven A. J. Salamon
Director
May 5, 2025Option exercise+400,000$10.00$4.00M3,413,468
Steven A. J. Salamon
Director
Dec 24, 2024Conversion+250,000$10.00$2.50M3,013,468
Rosalind Advisors, Inc.
Director
Dec 24, 2024Conversion+250,000$10.00$2.50M3,013,468
Gil Aharon
Director
Dec 24, 2024Conversion+250,000$10.00$2.50M3,013,468
Gerard J. Michel
CHIEF EXECUTIVE OFFICER, Director
Oct 22, 2024Option exercise+16,666$6.00$100.00K319,334
Gil Aharon
Director
Apr 18, 2024Option exercise+619,946$6199.46$3.84B2,681,271
Gil Aharon
Director
Apr 18, 2024Conversion+991,615––2,681,271
Steven A. J. Salamon
Director
Apr 18, 2024Conversion+991,615––2,732,586
Steven A. J. Salamon
Director
Apr 18, 2024Option exercise+619,946$6199.46$3.84B2,732,586
Steven A. J. Salamon
Director
Apr 18, 2024Option exercise+619,946$0.01$6.20K2,732,586
Steven A. J. Salamon
Director
Apr 18, 2024Conversion+991,615––2,732,586
Gil Aharon
Director
Apr 18, 2024Option exercise+619,946$0.01$6.20K2,681,271
Gil Aharon
Director
Apr 18, 2024Conversion+991,615––2,681,271
Gil Aharon
Director
Apr 18, 2024Option exercise+619,946$0.01$6.20K2,763,468
Gil Aharon
Director
Apr 18, 2024Conversion+991,615––2,763,468
Rosalind Advisors, Inc.
Director
Apr 18, 2024Conversion+991,615––2,763,468
Rosalind Advisors, Inc.
Director
Apr 18, 2024Option exercise+619,946$6199.46$3.84B2,763,468
Steven A. J. Salamon
Director
Mar 19, 2024Buy+26,882$3.72$100.00K1,121,025
Gil Aharon
Director
Mar 19, 2024Buy+26,882$3.72$100.00K1,069,710
Sandra Pennell
SVP OF FINANCE, PFO AND PAO
Mar 19, 2024Award+26,881$3.72$100.00K61,052
Gerard J. Michel
CHIEF EXECUTIVE OFFICER, Director
Mar 19, 2024Award+40,323$3.72$150.00K302,668
David L. Hoffman
GEN'L COUNSEL, CCO & SECY
Mar 19, 2024Award+20,161$3.72$75.00K74,330
Vojo Vukovic
CHIEF MEDICAL OFFICER
Mar 19, 2024Award+26,882$3.72$100.00K126,882
Kevin Muir
GM INTERVENTIONAL ONCOLOGY
Mar 19, 2024Award+13,441$3.72$50.00K18,582
Vojo Vukovic
Chief Medical Officer
Dec 12, 2023Buy+40,000$3.00$120.00K100,000
Gerard J. Michel
Chief Executive Officer, Director
Dec 8, 2023Buy+34,000$2.94$99.96K262,345
Sandra Pennell
SVP of Finance, PFO and PAO
Nov 17, 2023Buy+30,000$2.43$72.90K30,000
Rosalind Advisors, Inc.
Director
Nov 17, 2023Buy+100,000$2.40$240.00K1,038,828
David L. Hoffman
See Remarks
Nov 16, 2023Buy+40,000$2.48$99.20K40,000
Vojo Vukovic
Chief Medical Officer
Nov 16, 2023Buy+60,000$2.48$148.80K60,000
John Purpura
Chief Operating Officer
Oct 13, 2023Buy+14,505$3.44$49.90K41,526
John Richard Sylvester
Director
Aug 21, 2023Buy+10,550$4.80$50.64K10,550
Gerard J. Michel
Chief Executive Officer, Director
Aug 18, 2023Option exercise+31,110$4.50$140.00K228,345
Gerard J. Michel
Chief Executive Officer, Director
Mar 29, 2023Buy+19,646$4.84$95.09K197,235
Steven A. J. Salamon
Director
Dec 14, 2022Buy+15,215$3.62$55.08K455,315
Rosalind Advisors, Inc.
Director
Dec 14, 2022Buy+15,215$3.62$55.08K459,315
Gerard J. Michel
Chief Executive Officer, Director
Dec 13, 2022Buy+51,725$2.90$150.00K177,589
Gerard J. Michel
Chief Executive Officer, Director
Jul 20, 2022Buy+62,814$3.98$250.00K125,864
John Purpura
Chief Operating Officer
May 16, 2022Buy+3,300$4.61$15.21K27,021
Steven A. J. Salamon
Director
May 13, 2022Buy+5,000$5.03$25.15K440,100
Steven A. J. Salamon
Director
May 12, 2022Buy+6,000$4.90$29.40K29,424
Rosalind Advisors, Inc.
Director
Apr 19, 2022Buy+1,600$6.25$10.00K433,100
Steven A. J. Salamon
Director
Apr 19, 2022Buy+1,600$6.25$10.00K429,100
Gil Aharon
Director
Apr 18, 2022Buy+2,000$6.35$12.70K404,000
Rosalind Advisors, Inc.
Director
Apr 18, 2022Buy+2,000$6.35$12.70K431,500
Gerard J. Michel
See Remarks, Director
Apr 18, 2022Buy+1,800$6.37$11.47K63,050
Gerard J. Michel
See Remarks, Director
Apr 18, 2022Buy+200$6.34$1.27K61,250
Steven A. J. Salamon
Director
Apr 13, 2022Buy+1,500$6.45$9.68K427,500

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
8.18%
2M shares short
Days to cover
5.7
At 0M shares a day
Change since last report
-5.7%
From 2M shares
Short volume, 20 days
33.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Delcath Systems's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,481 shares on Aug 24, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Roger G. Stoll Phd
Retired
Jul 9, 20241,000$7.29KJul 9, 2024Stock Options

Congress trades

1 trade in Delcath Systems reported by 1 member of the House

MemberTypeTradedAmountFiled
Roger W. Marshall
KS01 · child
SoldJun 9, 2017$1K–15KAug 6, 2018
423 days late

See a number that looks wrong?